Off-Label Use and the Spectre of Drug-Eluting Stent Thrombosis

被引：1
|
作者：
Cook, Stephane [1 ]
Wenaweser, Peter [1 ]
机构：
[1] Swiss Cardiovasc Ctr, Bern, Switzerland
来源：
CIRCULATION-CARDIOVASCULAR INTERVENTIONS | 2009年 / 2卷 / 04期
关键词：
Editorials; stents; BARE-METAL STENTS; OUTCOMES; IMPLANTATION; PREDICTORS; EFFICACY; THERAPY; SAFETY; RISK;
D O I：
10.1161/CIRCINTERVENTIONS.109.891218
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：273 / 276
页数：4
相关论文
共 50 条
  • [1] Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents
    Win, Htut K.
    Caldera, Angel E.
    Maresh, Kelly
    Lopez, John
    Rihal, Charanjit S.
    Parikh, Manish A.
    Granada, Juan F.
    Marulkar, Sachin
    Nassif, Deborah
    Cohen, David J.
    Kleiman, Neal S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (18): : 2001 - 2009
  • [2] Safety of drug-eluting stent use for off-label indications
    Brunner-La Rocca, H. P.
    Kaiser, C.
    Leibundgut, G.
    Nietlispach, F.
    Pfisterer, M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 679 - 679
  • [3] Off-label use of drug-eluting stents - Reply
    Beohar, Nirat
    Davidson, Charles J.
    Kip, Kevin E.
    Vlachos, Helen A.
    Williams, David O.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (08): : 859 - 860
  • [4] Delayed Arterial Healing Is Associated With Late Stent Thrombosis in Off-Label Use of Drug-Eluting Stents: A Pathologic Study
    Nakazawa, Gaku
    Farb, Andrew
    Vorpahl, Marc
    Finn, Aloke V.
    Kolodgie, Frank D.
    Virmani, Renu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A7 - A7
  • [5] Association Between Off-Label Use of Drug-Eluting Stents and Subsequent Stent Thrombosis: A Case-Control Analysis
    Rabinovitz, Asaf
    Bier, Dara M.
    Wagman, Gabriel M.
    Charlap, Esti
    Nazari, Reza
    Ghitelman, Jaime
    Celaj, Sulejman
    Skeif, Basel
    Menegus, Mark
    Srinivas, V. S.
    JOURNAL OF INVASIVE CARDIOLOGY, 2010, 22 (01): : 15 - 19
  • [6] The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use
    Hoffmann, Rainer
    Klinker, Helene
    Adamu, Umar
    Kelm, Malte
    Blindt, Ruediger
    CLINICAL RESEARCH IN CARDIOLOGY, 2009, 98 (09) : 549 - 554
  • [7] The risk of definitive stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use
    Rainer Hoffmann
    Helene Klinker
    Umar Adamu
    Malte Kelm
    Rüdiger Blindt
    Clinical Research in Cardiology, 2009, 98 : 549 - 554
  • [8] Off-label use of drug-eluting stents: assessing the risk
    Mehran, Roxana
    Dangas, George D.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (11): : 594 - 595
  • [9] Off-label use of drug-eluting stents: assessing the risk
    Roxana Mehran
    George D Dangas
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 594 - 595
  • [10] Off-label use of drug-eluting stents - Putting it in perspective
    Grines, Cindy L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (06) : 615 - 617
12345